Arena’s (ARNA) Q4 Loss Narrower but Revenues Fall Short
Arena Pharmaceuticals, Inc. ARNA reported a loss of ArrayArray cents per share (adjusted for restructuring expenses and one-time items) in the fourth quarter of 20Array5, narrower than the year-ago loss of Array4 cents per share. The Zacks Consensus Estimate was also a loss of Array4 cents. […]